Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has announced the launch of a new specialized Microbiome Service. The service will provide access to advanced microbiome testing and analysis to support precision medicine, clinical research, and personalized healthcare for women, children and young people.
Combining cutting-edge sequencing technologies with multidisciplinary research expertise, the private-paid service will be provided to academic and industry investigators. It will help identify the role of the human microbiome in health and disease. By analyzing the complex communities of microorganisms that naturally inhabit the body, the service supports clinicians and researchers in advancing diagnosis, treatment strategies, and disease prevention across a range of conditions.
Building on this momentum, Sidra Medicine has announced that it will be hosting its second MENA Microbiome Conference from 17 to 18 October 2026.
The launch of the Microbiome Service reflects Sidra Medicine's continued investment in precision medicine and translational research, while strengthening Qatar's position as a regional hub for scientific innovation and personalized healthcare.
The service was launched by the Laboratory of Microbiome and Biomarkers Discovery to support researchers particularly in the MENA region, who either lack the expertise or the infrastructure to process their samples.
